453 related articles for article (PubMed ID: 20527935)
21. MicroRNA-155 and microRNA-196b: promising biomarkers in hepatitis C virus infection?
Kałużna EM
Rev Med Virol; 2014 May; 24(3):169-85. PubMed ID: 24591085
[TBL] [Abstract][Full Text] [Related]
22. Construction and identification of a human liver specific microRNA eukaryotic expression vector.
Chen S; Ni M; Yu B; Lv T; Lu M; Gong F
Cell Mol Immunol; 2007 Dec; 4(6):473-7. PubMed ID: 18163960
[TBL] [Abstract][Full Text] [Related]
23. High-throughput luciferase reporter assay for small-molecule inhibitors of microRNA function.
Connelly CM; Thomas M; Deiters A
J Biomol Screen; 2012 Jul; 17(6):822-8. PubMed ID: 22412086
[TBL] [Abstract][Full Text] [Related]
24. Positive and negative modulation of viral and cellular mRNAs by liver-specific microRNA miR-122.
Jopling CL; Norman KL; Sarnow P
Cold Spring Harb Symp Quant Biol; 2006; 71():369-76. PubMed ID: 17381319
[TBL] [Abstract][Full Text] [Related]
25. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA.
Jopling CL; Yi M; Lancaster AM; Lemon SM; Sarnow P
Science; 2005 Sep; 309(5740):1577-81. PubMed ID: 16141076
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA-122 might be a double-edged sword in hepatocellular carcinoma.
Zhang R; Wang L; Yu GR; Zhang X; Yao LB; Yang AG
Hepatology; 2009 Oct; 50(4):1322-3. PubMed ID: 19591123
[No Abstract] [Full Text] [Related]
27. MicroRNA-18a prevents estrogen receptor-alpha expression, promoting proliferation of hepatocellular carcinoma cells.
Liu WH; Yeh SH; Lu CC; Yu SL; Chen HY; Lin CY; Chen DS; Chen PJ
Gastroenterology; 2009 Feb; 136(2):683-93. PubMed ID: 19027010
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-224 is upregulated in HepG2 cells and involved in cellular migration and invasion.
Li Q; Wang G; Shan JL; Yang ZX; Wang HZ; Feng J; Zhen JJ; Chen C; Zhang ZM; Xu W; Luo XZ; Wang D
J Gastroenterol Hepatol; 2010 Jan; 25(1):164-71. PubMed ID: 19793168
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance and potential of hepatic microRNA-122 expression in hepatitis C.
Morita K; Taketomi A; Shirabe K; Umeda K; Kayashima H; Ninomiya M; Uchiyama H; Soejima Y; Maehara Y
Liver Int; 2011 Apr; 31(4):474-84. PubMed ID: 21199296
[TBL] [Abstract][Full Text] [Related]
30. Analysis of sequence variations in 59 microRNAs in hepatocellular carcinomas.
Yang J; Zhou F; Xu T; Deng H; Ge YY; Zhang C; Li J; Zhuang SM
Mutat Res; 2008 Feb; 638(1-2):205-9. PubMed ID: 17900631
[TBL] [Abstract][Full Text] [Related]
31. Low-dose IL-2 therapy reduces HCV RNA and HBV DNA: case report.
Tomova R; Antonov K; Ivanova A; Jacobs JJ; Koten JW; Den Otter W; Krastev Z
Anticancer Res; 2009 Dec; 29(12):5241-4. PubMed ID: 20044643
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA miR-122 as a therapeutic target for oligonucleotides and small molecules.
Thomas M; Deiters A
Curr Med Chem; 2013; 20(29):3629-40. PubMed ID: 23745562
[TBL] [Abstract][Full Text] [Related]
33. Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in human cancer cells.
Tsang WP; Kwok TT
J Nutr Biochem; 2010 Feb; 21(2):140-6. PubMed ID: 19269153
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cells.
Yao Q; Xu H; Zhang QQ; Zhou H; Qu LH
Biochem Biophys Res Commun; 2009 Oct; 388(3):539-42. PubMed ID: 19682430
[TBL] [Abstract][Full Text] [Related]
35. Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma.
Liu M; Wu H; Liu T; Li Y; Wang F; Wan H; Li X; Tang H
Cell Res; 2009 Jul; 19(7):828-37. PubMed ID: 19546886
[TBL] [Abstract][Full Text] [Related]
36. DDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-associated hepatocellular carcinoma and is involved in cell growth control.
Chang PC; Chi CW; Chau GY; Li FY; Tsai YH; Wu JC; Wu Lee YH
Oncogene; 2006 Mar; 25(14):1991-2003. PubMed ID: 16301996
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA silencing in primates: towards development of novel therapeutics.
Petri A; Lindow M; Kauppinen S
Cancer Res; 2009 Jan; 69(2):393-5. PubMed ID: 19147547
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA and hepatocellular carcinoma: biology and prognostic significance.
Milazzo M; Fornari F; Gramantieri L
Minerva Gastroenterol Dietol; 2011 Sep; 57(3):257-71. PubMed ID: 21769076
[TBL] [Abstract][Full Text] [Related]
39. HCV-hepatocellular carcinoma: new findings and hope for effective treatment.
Dash S; Haque S; Joshi V; Prabhu R; Hazari S; Fermin C; Garry R
Microsc Res Tech; 2005 Nov; 68(3-4):130-48. PubMed ID: 16276514
[TBL] [Abstract][Full Text] [Related]
40. Single-Vehicular Delivery of Antagomir and Small Molecules to Inhibit miR-122 Function in Hepatocellular Carcinoma Cells by using "Smart" Mesoporous Silica Nanoparticles.
Yu C; Qian L; Uttamchandani M; Li L; Yao SQ
Angew Chem Int Ed Engl; 2015 Sep; 54(36):10574-8. PubMed ID: 26179591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
